Medicine and Dentistry
Patient
100%
Guillain-Barré Syndrome
45%
Syndrome
28%
Randomized Controlled Trial
27%
Immunoglobulin
26%
Plasma Exchange
26%
Thymectomy
22%
Central Nervous System Infection
22%
Beta1a Interferon
22%
Polyneuropathy
22%
Cerebrospinal Fluid
22%
Immunosuppressive Treatment
22%
Infection
22%
Consumer
22%
Systematic Review
22%
Obstetrics
22%
Woman
22%
Disability
21%
Therapeutic Procedure
17%
Neuropathy
15%
Sensory Neuropathy
11%
Multifocal Motor Neuropathy
7%
Clinical Feature
6%
Logistic Regression Analysis
5%
Analysis
5%
Adult
5%
Neuromuscular Disease
5%
Inflammatory Disorder
5%
Mortality
5%
Child
5%
Therapeutics
5%
Base
5%
Supportive Care
5%
Central Nervous System Viral Infections
5%
Symptom
5%
Neuroscience
Guillain-Barre Syndrome
91%
Randomized Controlled Trial
73%
Intravenous Immunoglobulin
45%
Corticosteroid
27%
Prednisolone
22%
Interferon
22%
Central Nervous System
22%
Interferon Beta 1a
22%
Neuromuscular Disorder
16%
Methotrexate
7%
Cyclophosphamide
7%
Ciclosporin
7%
Peripheral Nervous System
5%
Methylprednisolone
5%
Nursing and Health Professions
Guillain Barre Syndrome
22%
Cost Utility Analysis
22%
Cochrane Library
22%
Quality Control
22%
Midwife
6%
Economic Evaluation
5%
Patient
5%
Cost Effectiveness Analysis
5%
Adult
5%